Actively Recruiting
Isometric Resistance Exercise for Hypertension
Led by Chinese University of Hong Kong · Updated on 2025-12-29
390
Participants Needed
2
Research Sites
142 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Isometric resistance exercises (IREs) have great potential to improve blood pressure (BP) control. However, the effectiveness of IREs in reducing HT is still unknown because their hypotensive effects have not been detected using ambulatory BP measurements (ABPM), which are the current standard for BP measurement. Methods: This first adequately-powered RCT will involve 390 patients with HT who do not meet the current physical activity guidelines defined by the World Health Organization. Participants will be randomly assigned in a 1:1 ratio using stratified and blocked randomization to either the IRE (wall squat) group or stretching exercise (active control) group. A well-structured, widely accepted, and validated 24-week wall squat program (2 minutes per exercise, 2 minutes of rest between sets, and 3 sessions per week) will be implemented, as it has been commonly used in previous research. Adherence to the program will be monitored using smartwatches, and regular contact with patients through social media will help ensure adherence. All patients will be followed up for 1 year to investigate the long-term effects of IREs on BP. Control group will receive exact same treatment except that IRE is replaced by frequency-matched and time-matched stretching exercise. The primary outcome measure will be systolic daytime ABPM BP at 24 weeks. Secondary outcome measures will include other BP and ABPM parameters at 12 weeks, 24weeks and 1year, cfPWV at baseline, 24 weeks and 1year, and FMD at baseline and 24weeks. Safety data will be collected and reported.
CONDITIONS
Official Title
Isometric Resistance Exercise for Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- A suboptimal daytime systolic blood pressure of >135-160 mmHg on a 24-hour ambulatory blood pressure monitoring
- No regular physical activity or less than 150 minutes of moderate-intensity aerobic exercise per week
- Stable doses of anti-hypertension medication for at least 4 weeks if receiving drug treatment
- Agreement to no changes in blood pressure medications during the 24-week intervention period
You will not qualify if you...
- Unable or unwilling to provide informed consent
- Unwillingness to repeat ambulatory blood pressure monitoring
- Relative contraindications to ambulatory blood pressure monitoring such as diagnosed atrial fibrillation, nighttime workers, occupational drivers, or bleeding tendencies
- Severe osteoarthritis pending knee replacement surgery
- Known secondary hypertension
- Use of 3 or more anti-hypertension medications at maximum doses or 4 or more anti-hypertension medications
- Systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg on ambulatory monitoring at baseline or 12 weeks
- Pregnancy or breastfeeding
- Active malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Lek Yuen General Outpatient Clinic
Hong Kong, Hong Kong, 00000
Actively Recruiting
2
School of public health and primary care
Hong Kong, Hong Kong
Actively Recruiting
Research Team
E
Eric Kam-Pui Lee, MSc, FRACGP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here